|
⚲
|
| Keyboard |
| Piper Brian
✚
|
|
|---|---|
| CIK # | 0001665924 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001665924] | |
| 4 | [0001665924] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Sana Biotechnology Inc | |
| Piper Brian | |
| Prelude Therapeutics Inc | |
| Medgenics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Sana Biotechnology Inc SANA
Stock Option (Right to Buy) · derivative
|
2026-02-17 | Grant | 900,000 | $0.00 | |
|
Sana Biotechnology Inc SANA
Restricted Stock Units · derivative
|
2026-02-17 | Grant | 200,000 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Common Stock
|
2021-08-25 | Sell | 2,344 | $34.33 | 80,470 |
|
Prelude Therapeutics Inc PRLD
Common Stock
|
2021-08-25 | Option exercise | 8,333 | $1.89 | 15,749 |
|
Prelude Therapeutics Inc PRLD
Employee Stock Option (Right to Buy) · derivative
|
2021-08-25 | Option exercise | 8,333 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Common Stock
|
2021-08-25 | Sell | 2,100 | $32.44 | 68,124 |
|
Prelude Therapeutics Inc PRLD
Common Stock
|
2021-08-25 | Sell | 3,889 | $33.23 | 129,231 |
|
Prelude Therapeutics Inc PRLD
Employee Stock Option (Right to Buy) · derivative
|
2021-07-20 | Grant | 115,650 | $0.00 | |
|
Prelude Therapeutics Inc PRLD
Common Stock
|
2021-05-25 | Sell | 1,736 | $35.45 | 61,541 |
|
Prelude Therapeutics Inc PRLD
Common Stock
|
2021-05-25 | Sell | 3,110 | $33.53 | 104,278 |
|
Prelude Therapeutics Inc PRLD
Common Stock
|
2021-05-25 | Sell | 399 | $36.09 | 14,400 |
|
Prelude Therapeutics Inc PRLD
Common Stock
|
2021-05-25 | Sell | 3,088 | $34.11 | 105,332 |
|
Prelude Therapeutics Inc PRLD
Common Stock
|
2021-05-25 | Option exercise | 8,333 | $1.89 | 15,749 |
|
Prelude Therapeutics Inc PRLD
Employee Stock Option (Right to Buy) · derivative
|
2021-05-25 | Option exercise | 8,333 | $0.00 | |
|
Medgenics Inc GNMX
Stock Option (Right to Purchase) · derivative
|
2018-06-14 | Grant | 238,000 | $0.00 | |
|
Medgenics Inc GNMX
Stock Option (Right to Purchase) · derivative
|
2018-05-14 | Grant | 270,000 | $0.00 | |
|
Medgenics Inc GNMX
Stock Option (Right to Purchase) · derivative
|
2017-08-11 | Grant | 380,000 | $0.00 | |
|
Medgenics Inc GNMX
Stock Option (Right to Purchase) · derivative
|
2017-02-17 | Grant | 190,000 | $0.00 | |
|
Medgenics Inc MDGN
Option Award (right to buy) · derivative
|
2016-04-15 | Grant | 150,000 | $0.00 |